Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab. (Q44435206)
Jump to navigation
Jump to search
scientific article published in May 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab. |
scientific article published in May 2003 |
Statements
Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab (English)
Regina Loomis
Rocco Carbone